Circumvention of common labelling artefacts using secondary nanobodies

Abstract
A standard procedure to study cellular elements is via immunostaining followed by optical imaging. This methodology typically requires target-specific primary antibodies (1.Abs), which are revealed by secondary antibodies (2.Abs).Unfortunately, the antibody bivalency, polyclonality, and large size can result in a series of artifacts. Alternatively, small, monovalent probes, such as single-domain antibodies (nanobodies), have been suggested. The discovery and validation of nanobodies against specific targets are challenging, thus only a minimal amount of them are currently available. Here, using STED, DNA-PAINT, and light-sheet microscopy, we demonstrate that secondary nanobodies 1) increase localization accuracy compared to 2.Abs; 2) allow direct pre-mixing with 1.Abs before staining, reducing experimental time, and enabling the use of multiple 1.Abs from the same species; 3) penetrate thick tissues more efficiently; and 4) avoid artificial probe-induced clustering of target molecule seen with conventional 2.Abs in living or poorly fixed samples. Altogether, showing that secondary nanobodies are a valuable alternative to 2.Abs.
Funding Information
  • Deutsche Forschungsgemeinschaft (Graduate School of Quantitative Biosciences Munich, Cluster of Excellence Nanoscale Microscopy, Molecular Physiology of the Brain (CNMPB), SFB 1032 (Nanoagents for spatiotemporal control of molecular and cellular reactions, Project A11), Emmy Noether Program (DFG JU 2957/1-1), Germany's Excellence Strategy–EXC 2067/1-390729940, SFB1286/Z3)
  • European Research Council (MolMap, grant agreement no. 680241)
  • Max-Planck-Gesellschaft
  • Center for NanoScience, Ludwig-Maximilians-Universität München